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SConclusions: The incidence of jailed DFA was acceptable and coverage of DFA in
stenting the proximal SFA had higher primary patency, especially with intraluminal
approach.
TCT-535
Correlation of Toe-Brachial Indices with Infragenicular Arterial Patency in
Critical Limb Ischemia
Jessen Jacob1, Matthew C. Bunte1, Michael Maier1, Mehdi Shishehbor1
1Cleveland Clinic, Cleveland, OH
Background: Current ACC/AHA guidelines recommend toe-brachial indices (TBI)
for diagnosis of peripheral arterial disease when ankle-brachial indices are unreliable
due to non-compressible vessels. We sought to investigate how well TBI correlates
with Rutherford classiﬁcation and infragenicular arterial patency in critical limb
ischemia (CLI).
Methods: Between July 2011 and February 2013, among patients who presented to
the Cleveland Clinic Lower Extremity Wound Clinic with Rutherford Category 4-6
symptoms, 41 patients had TBI and lower extremity angiography performed. The
correlation between TBI, Rutherford Category, and infragenicular arterial patency was
evaluated.
Results: The median TBI for Rutherford Category 4, 5, and 6 symptoms was
0.320.25 (SD), 0.240.29 (SD), and 0.300.20 (SD), respectively. The median TBI
for 0, 1, 2, and 3-vessel runoff was 0.250.36 (SD), 0.260.21 (SD), 0.290.20
(SD), and 0.430.29 (SD), respectively. There was no statistically signiﬁcant
difference between TBI and Rutherford category (p¼0.42) or number of patent runoff
vessels below the knee (p¼0.80).Conclusions: In a small population of patients, TBI had a non-signiﬁcant correlation
with infragenicular runoff. TBI did not correlate with Rutherford classiﬁcation.
Patients with a high index of clinical suspicion for CLI should undergo further
angiographic evaluation when revascularization may improve outcomes.
TCT-536
Pooled Analysis of the CONFIRM Registries: Outcomes in Elderly Patients
Treated with Orbital Atherectomy for Peripheral Arterial Disease
Michael Lee1
1UCLA Medical Center, Los Angeles, CA
Background: The elderly represent a growing population of patients in the
community. There is a paucity of data about the outcomes of elderly patients with
peripheral arterial disease who undergo orbital atherectomy.
Methods: Our analysis of the CONFIRM I-III registries includes 2995 real-world
patients (4557 lesions) with 1753 patients <75 years of age (2637 lesions) and 1753
patients 75 years of age (1920 lesions) treated with orbital atherectomy. The primary
endpoint was the composite of dissection, perforation, slow ﬂow, vessel closure,
spasm, embolism, and thrombus formation.
Results: Patients 75 years of age had a high proportion of females (47.5% vs.
35.3%, p<0.001), more patients with critical limb ischemia, longer mean lesion length
(75.0  74.1 vs. 69.9  68.9 mm, p¼0.01), and more treatment location below the
knee 38.4% vs. 34.1%, p<0.001). Patients <75 years of age and 75 years of age had
similar rates of the primary end point (22.0% vs. 21.3%, p¼0.81), dissection (11.4%
vs. 10.5%, p¼0.72), vessel closure (1.7% vs. 1.1%, p¼0.13), spasm (6.3% vs. 6.4%,
p¼0.96), and embolism (2.5% vs. 1.6%, p¼0.31). Patients 75 years of age had less
incidence of thrombus formation (0.9% vs. 1.6%, p¼0.03) but higher perforation rate
(1.2% vs. 0.4%, p¼0.007) and a trend towards a higher rate of slow ﬂow (5.3% vs.
4.0%, p¼0.08).
Conclusions: Plaque modiﬁcation with orbital atherectomy provided similar clinical
outcomes in the patients <75 years of age and 75 years of age despite the elderly
having unfavorable baseline clinical and lesion characteristics including more patients
with critical limb ischemia, longer lesions, and treatment below the knee. The higher
rates of perforation and trend towards increased slow ﬂow may be explained by more
extensive disease and smaller vessels.B162 JACC Vol 62/18/Suppl B j October 27–NTCT-537
Long-term Outcomes of Self-Expanding Nitinol Stent Implantation for Chronic
Total Occlusion of the Superﬁcial Femoral and Proximal Popliteal Artery
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Background: Although recent guideline show expanded indication of endovascular
therapy (EVT) for superﬁcial femoral and proximal popliteal artery (SFPA) lesion,
only secondary patency rate after self-expanding nitinol stent implantation is
comparable for vein-graft bypass. Long-term outcomes are necessary for stent
implantation to be considered as ﬁrst-line therapy. This study investigated the long-
term patency rates and predictors of restenosis after self-expanding nitinol stent
implantation for chronic total occlusion (CTO) in SFPA lesions.
Methods: From January 2004 to December 2011, 2742 patients with peripheral artery
disease of SFPA lesion 3471 limbs underwent EVT with a self-expanding nitinol stent
at 13 institutions in Japan. Of the cohort, 1036 patients, 1169 limbs, had stents
implanted for CTOs in the SFPA and were followed as long as 8 years (mean
899607 days). We retrospectively investigated baseline characteristics, patency
rates, clinical outcomes and predictors of loss of primary patency.
Results: Mean age was 739 years and 28% were female patients. Fifty-nine percent
of the patients had diabetes mellitus and 27% were patients with critical limb
ischemia. Occluded length was 18485 mm, 74% was TASC II type C, D lesion.
Mean total stent length was 20389 mm and mean stent diameter was 6.70.8 mm,
mean ﬁnal balloon diameter was 5.20.8 mm. Fifty-two percent administrated cil-
ostazole. Incidence of stent fracture was 6%. Primary, assisted primary, secondary
patency rates were 42%, 63%, 76%, respectively. Mortality rate was 14%, 2.5% went
to surgical bypass, 2.7% had major amputation. In the multivariate analysis, stent
fracture (OR 2.52; p¼0.0016), female gender (OR 1.73; p¼0.0005), use of distal
puncture technique (OR 1.50; p¼0.0096), diabetes mellitus (OR 1.43; p¼0.0148),
ﬁnal balloon diameter (OR 0.23; p¼0.0075), administration of cilostazol (OR 0.65;
p¼0.0052) and use of IVUS (OR 0.71; p¼0.0342) were factors strongly associated
with loss of primary patency.
Conclusions: Although primary patency was low, secondary patency rate was
acceptable.
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Catheter directed thrombolysis in deep venous thrombosis with or without
pulmonary thromboembolism
Maddury Jyotsna1, Abhisheka K. Tripathi2
1Nizam's institute of medical sciences, Hydrabad, IN, 2Nizam's institute of medical
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Background: As deep venous thrombosis (DVT) treatment with anticoagulation does
not resolve the thrombus formed in the vein, we wanted to study the result of catheter
directed thrombolysis (CDT) in patients with acute DVT with or without pulmonary
thromboembolism (PTE).
Methods: We retrospectively analysed the data of patients who presented with acute
(< 10 days) or sub-acute (< 21 days) or acute on chronic DVT with or without PTE
and were given CDT through Multi-Side port Catheter Infusion Sets Dual Check
Valve 5F perfusion catheter (65 or 100cm from Cook's company), in our unit in the
year 2012. CDT was done with streptokinase, 250,000 U as a loading dose over 30
minutes, followed by 100,000 U/h over 24 hours. CT pulmonary angio and venous
colour Doppler was done before and 24 hrs after CDT was done. Success of CDT was
deﬁned as complete or partial depending on complete or reduction of thrombus burden
in pulmonary arteries &/or deep veins.
Results: A total of 22 patients presented with Acute DVT in our unit [15 (68.2%)
males and 7 (31.8%) females with mean age of 42.6  13.6 yrs ] in 2012. Out of
them 11 (50%) had PTE, 6 massive and 5 sub massive and 9 had PAH . 14(63.6%)
had Acute, 4 (18.2%) had sub-acute & 4 (18.2%) had acute on chronic DVT. 8
patients had predisposing factors (immobilization 4, adrenal adenoma 1, hyper-
homocysteinemia 1, haemodialysis related 1, venous stenosis 1). Simultaneously
IVC ﬁlter implantation in 12 (54.5%) and venous stenting in one patient was done.
After 24 hrs of CDT , 11 (50%) DVT patients had complete resolution of thrombus
and 11 (50%) had partial resolution (even in this group proximal thrombus in iliac
veins was disappeared in all except one). Out of 11 patients who had PTE, 8 had
complete resolution of thrombus and 3 had partial. Pulmonary artery pressure
normalized in 7 (7/9- 77.8%). In 3 patients IVC ﬁlters were retrieved. One patient had
puncture site hematoma which was managed conservatively. No fatal complication
was noted.ovember 1, 2013 j TCT Abstracts/POSTER/Endovascular Intervention







SConclusions: CDT results excellent resolution of thrombus burden and PAH in
patients with acute or sub-acute DVT with or without PTE without any signiﬁcant
complication.
TCT-539
Differences in Patients’ Selection and Outcomes of SilverHawk Atherectomy
versus Laser Atherectomy in Treating In-Stent Restenosis of the Femoropopliteal
Arteries: A Retrospective Analysis from a Single Center
Nicolas W. Shammas1, Gail A. shammas1, Michael Jerin1
1Midwest Cardiovascular Research Foundation, Davenport, IA
Background: Treatment of in-stent restenosis (ISR) of the femoropopliteal (FP) artery
remains a challenge to the endovascular specialist. Silverhawk (SA) and excimer laser
atherectomy (ELA) use different mechanisms in restenotic tissue reduction. We report
data on FP ISR treatment with SA and ELA in an unselected cohort of patients treated
at a single center.
Methods: Demographic, clinical, angiographic and procedural data was collected on
all patients that underwent SA and ELA (laser Elite 83.3%, Booster or Tandem
16.7%) for FP ISR from January 2005 until June 2010. Major adverse events and one-
year target lesion revascularization (TLR) were obtained by review of medical records
and phone calls. Univariate analysis was used to compare the 2 groups. Cox
Regression analysis for TLR over time was performed to adjust for differences
between the 2 cohorts and modeled for the following variables: SA vs. ELA, lesion
length, TASC D lesions (versus A-C), diabetes, age, gender and bail out stenting.
Results: 81 consecutive patients (41 SA, 40 ELA) were included in the analysis. ELA
was utilized more frequently in longer lesions, subacute presentation, TASC D
lesions, and in patients with more angiographic thrombus. Percent stenosis post ELA
was 56.6%  0.7% vs SA 33.8%  7.5% (p¼0.015). Percent stenosis post ELA was
56.6%  0.7% vs SA 33.8%  7.5% (p¼0.015). Final angiographic success (< 30%
residual narrowing post ﬁnal treatment) was similar between ELA and SA respectively
(92.5% vs. 100%, p¼0.12). Embolic ﬁlter protection was used equally in both
modalities (ELA 57.5% vs. SA 56.1%, p¼1.00). DE requiring treatment occurred in
2.5% in ELA vs 7.3% of SA (p¼0.2). There were no device related complications.
The primary outcome of TLR at 1 year occurred in 48.7% and 31.7% of ELA and SA
respectively (p¼0.171). ELA had a steeper failure rate than SA in the ﬁrst 6 months
post treatment and to a lesser extent after 6 months, whereas SA showed lesser TLR
initially but a higher TLR after 6 months. Cox Regression analysis showed that SA
was a predictor of TLR at 1 year.
Conclusions: Both SA and ELA continued to have high TLR rates in treating ISR of
the FP arteries. SA appears to be a predictor of TLR at 1 year.
TCT-540
Pooled Analysis of the CONFIRM Registries: Outcomes in Critical Limb
Ischemia Patients Treated for Peripheral Arterial Disease with Orbital
Atherectomy
Tony Das1, George Adams2, Jeffrey Indes3, Jihad A. Mustapha4
1Cardiology and Interventional Vascular Associates, Dallas, Texas, 2Rex Healthcare,
University of North Carolina, Raleigh, NC, 3Yale University School of Medicine, New
Haven, CT, 4Metro Health Hospital, Grand Rapids, MI
Background: Peripheral arterial disease (PAD) that results in critical limb
ischemia (CLI) is associated with signiﬁcant morbidity and mortality. Within the
ﬁrst year of diagnosis 25% of CLI patients will die and 30% will undergo
amputation. In this patient population that includes advanced age, diabetes, and renal
insufﬁciency, intra-arterial calcium is typically a predictor of poor endovascular
treatment success.
Methods: 3135 patients undergoing orbital atherectomy (OA) for treatment of PAD
were enrolled on an "all-comers" basis in 3 consecutive patient registries. All patients
were treated with the Orbital Atherectomy System manufactured by Cardiovascular
Systems, Inc. (St. Paul, MN). CONFIRM I evaluated the Diamondback360,
CONFIRM II evaluated the Predator360, and CONFIRM III evaluated Diamond-
back360, Predator360, and Stealth360. An analysis of the CLI data as it pertains to
the correlation of plaque morphology/calciﬁcation to the outcomes within the CLI
patient population after OA treatment was performed using the CONFIRM registry
series.
Results: 44% of the patients in the CONFIRM series had CLI (Rutherford
Categories 4-6) with documented lesion morphology, of which 87% presented with
moderate/severely calciﬁed lesions. There was no signiﬁcant difference in the
percentage of dissection (9.1% vs 12.2%), perforation (0.9% vs 0.6%), slow ﬂow
(5.7% vs 4.7%), closure (1.6% vs 1.2%), or spasm (6.4% vs 9.3%), in CLI
patients with moderate/severely calciﬁed lesions vs those without moderate/
severely calciﬁed lesions, respectively. Patients with CLI with moderate/severe
calcium had a lower rate of embolism (1.7% vs 5.2%, p¼0.01) and lower rate of
thrombus (0.9% vs 4.4%, p¼0.001) compared to patients without moderate/severely
calciﬁed lesions.
Conclusions: The majority of the CLI patients in this study had lesions with moderate
to severe calciﬁcation, yet the occurrence of adverse events was low after treatment
with orbital atherectomy. Orbital atherectomy is a safe tool for restoring blood ﬂow in
the lower extremities of CLI patients regardless of arterial calcium burden.JACC Vol 62/18/Suppl B j October 27–November 1, 2013 j TCT AbstrTCT-541
Preliminary results from the Jetstream navitus system Endovascular Therapy
post-market (JET) registry
Nicolas W. Shammas1, William A. Gray2, Lawrence Garcia3, Greg Kasper4
1Midwest Cardiovascular Research Foundation, Davenport, IA, 2Columbia
University Medical Center, New York, United States, 3St. Elizabeth's Medical Center,
Boston, MA, 4St Vincent's hospital, Toledo, OH
Background: Treatment of complex lesions in the femoropopliteal (FP) artery
including long, occluded, diffuse, thrombotic or calciﬁed lesions carries an increased
risk of major adverse events (MAE), reduced patency at 1 year and recurrent target
lesion revascularization (TLR). The post market multicenter JET registry is currently
evaluating the Jetstream atherectomy system in treating denovo or non stent restenotic
lesions of the FP artery.
Methods: JET is a multi-center, open-label, non-randomized registry in up to 75 sites
with a target enrolment of 500 patients, Rutherford category 1-3 and with denovo or non
stent restenotic FP lesions 4 cm in length and 70% in severity. Lesions with in-stent
restenosis, or crossed via a subintimal approach or treated within 1 month prior to index
procedure are excluded. The primary endpoint is binary stenosis at 12 months as deﬁned
by duplex ultrasound derived systolic velocity ratio>2.5. Secondary endpoints include
procedural success as deﬁned by successful revascularization of target vessel deﬁned as
 30% residual diameter stenosis following atherectomy  adjunctive therapy,
improvement in ankle-brachial index through 12 months compared to pre-procedural
baseline and MAE through 30 days. MAE is deﬁned as amputation, death, TLR, target
vessel revascularization, myocardial infarction, or angiographic distal embolization
requiring separate intervention or hospitalization. Index angiogram and duplex ultra-
sound assessment of binary stenosis will be evaluated by core laboratory.
Results: Preliminary results from the ﬁrst 60 patients enrolled in the JET registry are
as follows: mean age 65.5 yrs, males 68.3%, diabetics 50%, smoking history 63.4%,
hypertension 87.8%, Preprocedure ABI 0.68, non stent restenotic lesions 78.8%,
lesion length 174 mm, reference diameter 5.7 mm, pretreatment stenosis 90%, post
Jetstream stenosis 45% and post adjunctive treatment 9%. The JetStream total run was
3.52 min, adjunctive stenting was 30.9%. Distal embolic protection was used in only
3.6% of patients. There were no in-hospital complications.
Conclusions: Jetstream atherectomy of FP lesions appears to have a high procedural
success and reduced in-hospital complications.
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Background: The prognostic signiﬁcance of false lumen thrombus formation in type
B aortic dissection remains unclear.
Methods: Aortic dissection cases were identiﬁed from the Kaiser Permanente-
Registry of Aortic Dissections (KP-RAD). This is a population-based registry that
captures consecutive cases of aortic dissections among the approximately 3,000,000
health plan members in Southern California. The presence of any false lumen
thrombus by CT angiography during follow-up period was categorized as partial or
complete thrombus. The primary outcome was a composite of aorta related mortality,
myocardial infarction, stroke, aortic rupture, or dissection extension.
Results: There were 384 patients with type B aortic dissection, of which 293 had
a patent false lumen and 91 had partial or complete thrombosis. The mean age (SD)
for subjects with a patent false lumen was 69 (16) and 64 (13) with presence of false
lumen thrombus (p<0.001). There was no difference between groups for gender
(p¼0.20). The median follow up was 4 years with maximum follow-up of 7 years. The
cumulative incidence rate by presence or absence of false lumen thrombus was 30.0%
vs. 17.2% respectively (p¼0.01) (see ﬁgure).acts/POSTER/Endovascular Intervention B163
